Product Information

Homeopathy in the battle against eye aging deterioration

These German made products contain biological macromolecules from various tissues of the eye such as the retina, optic nerve, cornea, connective tissue, lens and vitreous (of bovine origin). There are currently two versions - A and B.

Conjunctisan A ®
Stimulating the natural healing process for aging eyes

Conjunctisan A ® stimulates the spontaneous natural healing process and normalization of eye function and has been proven to be highly successful in the treatment of cataract with a 67% improvement rate. But it also treats other degenerative eye complaints such as environmental agitation, general eye aging, eye strain etc. It is also known that regular users sometimes have to get weaker lenses for their glasses or indeed can do without their glasses for long periods, a clear indication of eyesight improvement.

With over fifteen years of use it is completely safe and suitable for prolonged use. Break a vial and instil a couple of drops into each eye two to several times daily. It should be stored in the fridge when not in use and open vials discarded after 24-hours.

Manufacturer's Insert

CONJUNCTISAN A ®

Composition:
One phial of 0.5ml contains, dissolved in 0.7& saline solution and 4% glycerol, the following macromolecular tissue extracts (standardized according to protein content- molecular weight <10x6, manufactured according to homeopathic methods 0.2ng (D10) bulb.oc.fet.,0.05ng (D11) lens, 0.1ng (D10) vasa fet., 0.15ng (D10) placenta fet., 0.05pg (D14) retina, 0.05pg (D14) nerv. opt., 0.1pg (D13) choriodea, 0.1pg (D13) corp. vitr., 0.05pg (D14) cortex cerebri, 0.05pg (D14) diencephalon, 0.074ug (D8) desacetyl lanatoside C, 5ug (D6) aesculin, 5ug (D6) dodecyl sodium sulphate.

Properties:
Biological macromolecules from various tissues of the eye, such as the retina, optic nerve, cornea, connective tissue, lens and vitreous body, have a regenerative effect on damaged tissue through the stimulation of spontaneous healing processes and the normalization of cell functions. The broad range of additional protoplasmic active factors from the brain, placenta and foetal vessels, in combination with vaso and surface active substances, opposes protein changes and cross-linkage.

Indications:
Senile cataract, macula degeneration’s, opacity of the lens and vitreous body, retina changes, degenerative eye complaints.

Dosage and Application:
Break off the upper part of the phial by twisting it. If no other dose regimen is recommended by the attending doctor, instill several times daily 1-2 drops in the conjunctival sac of the eye and possibly also inhale through the nose by applying slight pressure to the body of the phial.

Intolerance and Risks:
None, when used as prescribed.

Directions:
Separate one phial of Conjunctisan A® with the unit dose from the strip.

Twist the printed tag from the body of the phial.

Gently tap to bring the liquid into the narrow part of the phial.

Hold phial approximately in the middle, between thumb and index finger, squeeze gently with the tip of the finger.

Instill Conjunctisan A® in the unit dose into the conjunctival sac of the eye (support the hand for better control)- evenly distribute Conjunctisan A® by turning the eye- ensure pressure compensation after each drop.

Special Notes:
For the preservation of the full biological efficacy of Conjunctisan A®, these eye-drops are free from preservatives. The presentation in the form of phials with a unit dose permits the unrestricted action of organotherapeutic factors. Furthermore, this progressive method of applying eye drops excludes any risk of infection. Do not store at temperatures of more than 25 degrees Celsius. Keep the phials in the folding box, where they are protected from light. Only use clear solutions. Do not use drops after the expiry date marked. Keep drugs out of the reach of children. Solutions that have turned turbid through incorrect handling must not be used. For the indication of glaucoma, supervision by an eye specialist is recommended.